Matsudo, Japan

Shuji Okubo

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1982-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuji Okubo. Retrieved from https://idiyas.com/inventor/shuji-okubo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1982-1984

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Shuji Okubo

Introduction

Shuji Okubo is a notable inventor based in Matsudo, Japan. He has made significant contributions to the field of antibacterial compounds, holding a total of 3 patents. His work focuses on the production of novel antibiotics through microbial fermentation.

Latest Patents

One of his latest patents is for the antibacterial compound DC-38-V. This compound is produced by culturing a microorganism belonging to the genus Streptomyces. Another significant patent is for Antibiotic DC-11, which is produced by the fermentation of a microorganism from the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.

Career Highlights

Shuji Okubo is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His work has contributed to the development of effective antibacterial agents that can combat various infections.

Collaborations

Some of his notable coworkers include Fusao Tomita and Nobuo Nakamura. Their collaborative efforts have further enhanced the research and development of innovative antibacterial solutions.

Conclusion

Shuji Okubo's contributions to the field of antibacterial compounds highlight his role as a significant inventor in Japan. His innovative work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…